Investor homePress releasesFinancial reportsShare informationCEO's messageShareholder meetingsGovernance

Investor relations

Cell Impact AB is a global supplier of advanced metal flow plates and production technology to the hydrogen fuel cell and electrolyzer market. By using a scaleable unique technology – Cell Impact Forming™ – we can efficiently produce high-quality flow plates in large quantities. Our technology is substantially more compact, less resource-intensive, and environmentally friendly than conventional pressing methods.

...

SEK

...
(
...
%)
...
Volume:
...
...
Nasdaq First North Growth Market
The Share

IR contact

Pär Teike, CEO
+46 73-024 06 84
paer.teike@cellimpact.com

It was time for an update

2021-10-26

Cell Impact was listed on the Nasdaq First North Growth Market in 2013 and has grown substantially over the years. With a market capitalization of SEK 2.5 billion and upwards of 30,000 shareholders, it was time to refresh our investor pages.

Now available in English

As our investor community grows beyond Sweden, we felt the need to add English as a second language for those who don't speak Swedish. That's why most of our press releases (from 2019) and financial reports (from 2020) are also available in English.

Our goal remains - to serve the community with up-to-date, accurate information to simplify investment decisions. We hope that you will find our new IR site easy to navigate and a pleasure to use!

Pär Teike, CEO
Stefan Axellie, CFO

Karlskoga, Sweden

Files For Download
No items found.

Found a bug or have a suggestion?

2021-10-27

As with any new website, we are humble enough to acknowledge that we might have missed something. So if you find a bug or have a suggestion for something we haven't thought of, please feel free to let us know!


Just send an email to bugreport@cellimpact.com, and we'll have a look. Thank you!

Files For Download
No items found.

Latest press releases

View All
2021-11-18 20:08
REG
MAR

Updated indicative timetable for Cell Impact's fully guaranteed rights issue

Cell Impact AB (Nasdaq First North Growth Market: CI B) ("Cell Impact" or the "Company") today announces an updated indicative timetable for the fully guaranteed Rights Issue. The updated indicative timetable deviates from the previously communicated indicative timetable due to a postponed prospectus approval as a result of high workload for the Swedish Financial Supervisory Authority's prospectus unit.

Read more
2021-11-16 16:48
REG
MAR

Extraordinary general meeting of Cell Impact

An extraordinary general meeting of Cell Impact AB (publ) was held on 16 November 2021 whereby the shareholders, inter alia, authorized the board of directors to resolve upon issue of shares, warrants and/or convertibles.

Read more
2021-10-28 21:10
REG
MAR

Notice of extraordinary general meeting of Cell Impact

The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in an extraordinary general meeting on Tuesday 16 November 2021.

Read more
MAR
- Insider information
REG
- Regulatory
- Geographic restriction

Latest financial reports

View All
PDF

2021 Q3 quarterly report

Download
PDF
2021-10-22
Download
PDF

2021 Q2 quarterly report

Download
PDF
2021-08-25
Download
PDF

2021 Q1 quarterly report

Download
PDF
2021-05-07
Download
PDF

2020 annual report

Download
PDF
2021-03-26
Download
PDF

2020 Q4 year-end report

Download
PDF
2021-02-19
Download

Financial calendar

18

February
2022
2021 Q4 year-end report
Information provided by